Haemodialysis, atherosclerosis and inflammation - Identifying molecular mechanisms of chronic vascular disease in ESDR patients

Nephrology Dialysis Transplantation

Volumn 17, Issue SUPPL. 3, 2002, Pages 24-29

  Walter, Robert ^a   Mischak, Harald ^a,b   Haller, Hermann ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Mosaiques Diagnostics GmbH   (Germany)

Author keywords

Atherosclerosis; Cardiovascular disease; Haemodialysis; Inflammation

Indexed keywords

CHEMOKINE; CYTOKINE; GROWTH FACTOR;

ARTICLE; ATHEROSCLEROSIS; CELL ACTIVATION; CELL ADHESION; CELL MEMBRANE; CELL PROLIFERATION; CHRONIC DISEASE; CONTROLLED STUDY; DIALYSATE; FILTRATION; HEMODIALYSIS; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; KIDNEY FAILURE; KIDNEY FUNCTION; LEUKOCYTE; MASS SPECTROMETRY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; SMOOTH MUSCLE FIBER; THROMBOCYTE; VASCULAR DISEASE;

EID: 0036237772     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.suppl_3.24     Document Type: Article

References (73)

1. Patient survival among incident peritoneal dialysis and hemodialysis patients in an urban setting
2. Advance prediction of early death in patients starting maintenance dialysis
3. Monocyte expression of tissue factor and adhesion molecules: The link with accelerated coronary artery disease in patients with chronic renal failure
4. Cell proliferation in human coronary arteries
5. A modern view of atherogenesis
6. The pathogenesis of atherosclerosis: A perspective for the 1990s
7. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man
8. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
9. Growth factor production by endothelial cells
10. Cytokines and endothelial cell biology
11. Complement activation during extracorporeal therapy: Biochemistry, cell biology and clinical relevance
12. Hemodialysis hypotension: The interleukin-1 hypothesis
13. The sensation and regulation of interactions with the extracellular environment: The cell biology of lymphocyte adhesion receptors
14. Involvement of the immune system in human atherogenesis: Current knowledge and unanswered questions
15. Clinical relevance of cytokine production in hemodialysis
16. 2-Microglobulin-derived amyloidosis: An update
17. Inflammation, dyslipidemia and vascular risk factors in hemodialysis patients
18. Serum from hemodialysis patients inhibits basal and cytokine-stimulated tissue factor expression in vitro
19. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men
20. Biochemical markers of the acute coronary syndromes
21. End-stage renal disease, atherosclerosis and cardiovascular mortality: Is C-reactive protein the missing link?
22. Enhancement of reactive oxygen species production and cell surface markers expression due to haemodialysis
23. Enhanced production of nitric oxide by blood-dialysis membrane interaction
24. Cytokine production in hemodialysis
25. New molecular aspects of chronic uraemia and dialysis-related immunocompetent cells
26. Production of cytokines and cytokine inhibitory proteins in patients on dialysis
27. T-cell activation follows Th1 rather than Th2 pattern in haemodialysis
28. Immunologic function and survival in hemodialysis patients
29. Influence of dialysis with polyamide vs haemophan haemodialysers on monokines and complement activation during a 4-month long-term study
30. Characteristic cytokine products of Th1 and Th2 cells in hemodialysis patients
31. The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukins
32. Cytokines: Agents provocateurs in hemodialysis?
33. C5a induction of human IL-1 synergistic effect with endotoxin or interferon-gamma
34. Transcription not synthesis of IL-1 and tumor necrosis factor by complement
35. Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: Transcriptional signal provided by lipopolysaccharide or IL-1 itself
36. Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes
37. Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis
38. Leukocyte-endothelial cell interactions in haemodialysis-induced neutropenia
39. Differentially regulated cell surface expression of leukocyte adhesion receptors on neutrophils
40. Profound neutropenia during the early phase of hemodialysis
41. In vivo viability of 111-In-labelled granulocytes demonstrated in a sham-dialysis model
42. Phagocytic cell function as an index of biocompatibility
43. Impaired leucocyte rolling, adhesion and transendothelial migration following cuprophane haemodialysis
44. Reactive oxygen product formation by human neutrophils as an early marker for bioincompatibility of dialysis membranes
45. Cuprammonium membranes stimulate interleukin 1 release and arachidonic acid metabolism in monocytes in the absence of complement
46. Modulation of granulocyte LAM-1 and Mac-1 during dialysis-a prospective trial
47. Dialysis neutropenia: The role of the cytoskeleton
48. Transforming growth factor-beta is involved in the pathogenesis of dialysis-related amyloidosis
49. Cuprophane haemodialysis induces upregulation of LPS receptor (CD14) on monocytes: Role of complement activation
50. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS-binding protein
51. Membranes for dialysis
52. The quality of dialysate: An integrated approach
53. Innate immunity
54. Control of lipopolysaccharide (LPS)-binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes
55. CD11b CD18 acts in concert with CD14 and Toll-like receptor (TLR4) to elicit full lipopolysaccharide and Taxol-inducible gene expression
56. Effects of ultrapure and non-sterile dialysate on the inflammatory response during in vitro hemodialysis
57. Cytokine profiles during clinical high-flux dialysis: No evidence for cytokine generation by circulating monocytes
58. Endotoxins modulate chronically tumor necrosis factor α and interleukin 6 release by uraemic monocytes
59. Induction of IL-1 during hemodialysis: Transmembrane passage of intact endotoxins (LPS)
60. Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in vitro dialysis with whole blood
61. Haemodialysis membranes modulate chronically the production of TNFα, IL-1 β and IL-6
62. Permeability of dialyzer membranes to TNFα-inducing substance derived from water bacteria
63. The effect of ultrafiltered dialysate on the cellular content of interleukin-1 receptor antagonist in patients on chronic hemodialysis
64. Role of different dialysis membranes in the release of interleukin-6-soluble receptor in uremic patients
65. The effect of the dialysis membrane on cytokine release
66. Bioincompatibility-perspectives in 1993
67. Activation of human neutrophils after contact with cellulose-based haemodialysis membranes: Intracellular calcium signalling in single cells
68. Role for L-selectin in lipopolysaccharide-induced activation of neutrophils
69. Mechanism that regulate the functions of the selectins and their ligands
70. Flow cytometric study of in vitro neutrophil activation by biomaterials
71. Suppression der Synthese des Tumornekrosefaktors
72. Identification of the components of simple protein mixtures by high-accuracy peptide mass mapping and database searching